why choose us

First received: April 21, 2023

Clinical Trial: A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Solid Tumors

Study Type: INTERVENTIONAL


Official Title: An Open-label, Phase I Dose Escalation and Expansion Trial to Investigate Safety and Efficacy of BI 1821736 in Patients With Advanced Solid Tumors

Brief Summary: This study is open to adults with advanced solid tumours.People with solid tumours for whom previous treatment was not successful or no treatment exists can take part.The purpose of this study is to find the highest dose of a medicine called BI 1821736 that people with advanced solid tumours can tolerate.BI 1821736 is a type of immunotherapy.It is a special virus that kills cancer cells and helps the immune system fight cancer.In this study, BI 1821736 is given to humans for the first time.Participants receive BI…

Read more